4//SEC Filing
Tenenbaum Fabian 4
Accession 0001600132-19-000015
CIK 0001600132other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:29 PM ET
Size
5.3 KB
Accession
0001600132-19-000015
Insider Transaction Report
Form 4
Tenenbaum Fabian
Chief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2019-01-02+12,500→ 3,688,697 totalExercise: $0.88Exp: 2029-01-02→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]1. This option was granted on January 2, 2019. This option vests in quarterly installments over a four-years period from the date of grant.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeother
Related Parties
1- filerCIK 0001641300
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:29 PM ET
- Size
- 5.3 KB